# US 2024/0382569 A1 · Fungal enzyme mixtures and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0382569 A1
- Document ID: US20240382569A1
- Status: Published application
- Kind: A1
- Application number: 18/688,983
- Filed: 2022-09-02
- Published: 2024-11-21
- Earliest claimed: 2021-09-02
- Assignees: Bio-Cat, Inc.
- Applicants: Bio-Cat, Inc.
- Inventors: Sean Michael GARVEY; Kelly Marie TINKER; Morgan Dabney HOLLINS; Justin Lamont GUICE; Christopher SCHULER
- Web page: https://patentgrep.com/patent/US20240382569A1

## CPC

- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 38/488: {Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E}
- A23L 29/06: {Enzymes}
- A61K 38/465: {acting on ester bonds (3.1), e.g. lipases, ribonucleases}
- A61K 38/47: acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A61K 38/4813: {Exopeptidases (3.4.11. to 3.4.19)}
- A61K 38/482: {Serine endopeptidases (3.4.21)}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/14: Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- C12N 9/20: Triglyceride splitting, e.g. by means of lipase
- C12N 9/2411: {Amylases}
- C12N 9/2428: {Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase}
- C12N 9/62: from Aspergillus
- C12Y 301/01003: Triacylglycerol lipase (3.1.1.3)
- C12Y 302/01001: Alpha-amylase (3.2.1.1)
- C12Y 302/01003: Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
- C12Y 304/21063: Oryzin (3.4.21.63)
- C12Y 304/23018: Aspergillopepsin I (3.4.23.18)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Novel fungal enzyme compositions, and more particularly, enzyme mixtures comprising a plurality of fungal enzymes (e.g., from Aspergillus and Candida) are provided. The disclosure further relates to dietary supplements, foods and beverages containing these enzyme mixtures, and methods of making and using the same.

## Claims

### Claim 1

An enzyme mixture comprising a plurality of fungal enzymes from members of the genus Aspergillus and Candida, wherein the plurality of fungal enzymes comprises: (a) a protease obtained from A. oryzae, (b) a protease obtained from A. niger, (c) a protease obtained from A. melleus, (d) a lipase obtained from C. cylindracea or a lipase obtained from R. oryzae, (e) an amylase obtained from A. oryzae, and (f) a glucoamylase obtained from A. niger, wherein the enzyme mixture has exopeptidase, endopeptidase, lipase, alpha-amylase, and glucoamylase activities.

### Claim 2 (depends on 1)

The enzyme mixture of claim 1, wherein the enzymes are present as follows:
Enzyme
Units/Gram
protease from A. oryzae
10,000-1,000,000
HUT/g
protease obtained from A. niger
50-100,000
SAPU/g
protease obtained from A. melleus
10-10,000
LAPU/g
lipase obtained from C. cylindracea or
100-100,000
FIP/g
lipase obtained from R. oryzae
amylase obtained from A. oryzae
500-500,000
SKB/g
glucoamylase obtained from A. niger
5-5,000
AGU/g

### Claim 3 (depends on 1)

The enzyme mixture of claim 1, wherein the enzymes are present as follows:
Enzyme
Units/Gram
protease from A. oryzae
200,000-280,000
HUT/g
protease obtained from A. niger
1,000-1,400
SAPU/g
protease obtained from A. melleus
100-300
LAPU/g
lipase obtained from C. cylindracea or
10,000-14,000
FIP/g
fungal lipase obtained from R. oryzae
amylase obtained from A. oryzae
30,000-50,000
SKB/g
glucoamylase obtained from A. niger
75-125
AGU/g

### Claim 4 (depends on 1)

The enzyme mixture of claim 1, wherein the enzymes are present as follows:
Enzyme
Units/Gram
protease from A. oryzae
240,000
HUT/g
protease obtained from A. niger
1,200
SAPU/g
protease obtained from A. melleus
200
LAPU/g
lipase obtained from C. cylindracea or
12,000
FIP/g
lipase obtained from R. oryzae
amylase obtained from A. oryzae
40,000
SKB/g
glucoamylase obtained from A. niger
100
AGU/g

### Claim 5 (depends on 1, 2, 3, 4)

The enzyme mixture of any one of claims 1-4, wherein the ratio of the 3 fungal proteases: lipase:amylase:glucoamylase is:
a) 3600:120:400:1; or
b) 1800-5400:30-180:200-600:0.5-1.5;
as measured in hemoglobin unit tyrosine base units (HUT): Fédération Internationale Pharmaceutique units (FIP): Sandstedt, Kneen, and Blish method units (SKB): Amyloglucosidase units (AGU).

### Claim 6 (depends on 1, 2, 3, 4, 5)

The enzyme mixture of any one of claims 1-5, wherein the enzyme mixture comprises at least four, five, six, or seven of SEQ ID NOs: 1, 2, 3, 4, 5, 6, and 7.

### Claim 7 (depends on 1, 2, 3, 4, 5)

The enzyme mixture of any one of claims 1-5, wherein the enzyme mixture comprises SEQ ID NOs: 1, 2, 3, 4, 5, 6, and 7.

### Claim 8 (depends on 1, 2, 3, 4, 5)

The enzyme mixture of any one of claims 1-5, wherein the enzyme mixture comprises SEQ ID NOs: 1, 2, 3, 4, 5, and 6.

### Claim 9 (depends on 1, 2, 3, 4, 5)

The enzyme mixture of any one of claims 1-5, wherein the enzyme mixture comprises SEQ ID NOs: 1, 2, and 4-7.

### Claim 10 (depends on 1, 2, 3, 4, 5)

The enzyme mixture of any one of claims 1-5, wherein the enzyme mixture comprises amino acid sequences which share at least 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99% full-length sequence identity with any one of SEQ ID NOs: 1-7.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The enzyme mixture of any one of claims 1-10, in a dehydrated, powdered, granular or freeze dried form.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

A dietary supplement comprising the enzyme mixture of any one of claims 1-11.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

A dietary supplement comprising the enzyme mixture of any one of claims 1-11 and at least one additional enzyme comprising:
a) a lactase;
b) an alpha-galactosidase;
c) a beta-fructofuranosidase;
d) a cellulase;
e) papain; and/or
f) bromelain.

### Claim 14 (depends on 12, 13)

The dietary supplement of claim 12 or 13, wherein the dietary supplement is:
a) formulated as a tablet, capsule, chew, gummy, gum, or powder; and/or
b) a protein supplement or a nutritional supplement.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

A method for increasing protein digestion, fat digestion, carbohydrate digestion, absorption of amino acids, absorption of fatty acids, absorption of glucose, and/or absorption of iron comprising administering the enzyme mixture of any one of claims 1-11, or the dietary supplement of any one of claims 12-14, to a subject at least once per day.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

A method for decreasing the maximum plasma concentration of glucose comprising administering the enzyme mixture of any one of claims 1-11, or the dietary supplement of any one of claims 12-14, to a subject at least once per day.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

A method for lessening the frequency, duration, and/or severity of gastrointestinal symptoms including burping, cramping, distension, flatulence, nausea, reflux, borborygmus, and/or diarrhea comprising: administering the enzyme mixture of any one of claims 1-11, or the dietary supplement of any one of claims 12-14, to a subject at least once per day.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

A method for improving bowel function by improving stool frequency, stool consistency, and/or ease of stool passage comprising: administering the enzyme mixture of any one of claims 1-11, or the dietary supplement of any one of claims 12-14, to a subject at least once per day.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

A method for improving sleep quality comprising: administering the enzyme mixture of any one of claims 1-11, or the dietary supplement of any one of claims 12-14, to a subject at least once per day.

### Claim 20 (depends on 15, 16, 17, 18, 19)

The method any one of claims 15-19, wherein the dietary supplement is administered at least twice per day, at least three times per day, or at least four times per day.

### Claim 21 (depends on 15, 16, 17, 18, 19, 20)

The method of any one of claims 15-20, wherein the dietary supplement is administered to the subject before, after, or concurrently with a meal, food or beverage.

### Claim 22 (depends on 15, 16, 17, 18, 19, 20, 21)

The method of any one of claims 15-21, wherein the dietary supplement is administered in an amount effective to increase the rate of absorption of essential amino acids, branched chain amino acids, fatty acids, glucose, and/or iron in the subject.

### Claim 23 (depends on 15, 16, 17, 18, 19, 20, 21, 22)

The method of any one of claims 15-22, wherein the dietary supplement is administered to the subject in an amount effective to improve muscle health.

### Claim 24 (depends on 15, 16, 17, 18, 19, 20, 21, 22)

The method of any one of claims 15-22, wherein the dietary supplement is administered to the subject in an amount effective to improve digestive health.

### Claim 25 (depends on 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 15-24, wherein the subject is at least 40 years old.

### Claim 26 (depends on 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 15-24, wherein the subject is at least 60 years old.

### Claim 27 (depends on 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 15-26, wherein the subject consumes less than the daily recommended intake of nutrients, the subject experiences moderate gastrointestinal symptoms as measured by an average daily gastrointestinal score≥1 from the BF-GITFQ or average weekly daily gastrointestinal score≥1 from the GITQ, the subject has an average daily stool form score of 1, 2, 6, or 7 based on the Bristol Stool Form Scale, and/or the subject experiences poor sleep quality.

### Claim 28 (depends on 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The method of any one of claims 15-27, wherein the enzymes are present as follows:
Enzyme
Units/Dose
protease from A. oryzae
20,000-100,000
HUT/dose
protease obtained from A. niger
50-400
SAPU/dose
protease obtained from A. melleus
15-100
LAPU/dose
lipase obtained from C. cylindracea or
1,000-5,000
FIP/dose
lipase obtained from R. oryzae
amylase obtained from A. oryzae
5,000-20,000
SKB/dose
glucoamylase obtained from A. niger
10-100
AGU/dose

### Claim 29 (depends on 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The method of any one of claims 15-27, wherein the enzymes are present as follows:
Enzyme
Units/Dose
protease from A. oryzae
60,000
HUT/dose
protease obtained from A. niger
300
SAPU/dose
protease obtained from A. melleus
50
LAPU/dose
lipase obtained from C. cylindracea or
3,000
FIP/dose
lipase obtained from R. oryzae
amylase obtained from A. oryzae
10,000
SKB/dose
fungal glucoamylase obtained from A. niger
25
AGU/dose
